Deep Track Capital, LP
Q3 2025 13F Holdings
- Locationgreenwich, CT
- Num holdings
56
- Value ($000)
$3,583,282
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001856083
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
GH GUARDANT HEALTH INC | COM | 40131M109 | $259.55 M | 7 % | 4,154,086 | ||
ISI IONIS PHARMACEUTICALS INC | COM | 462222100 | $249.13 M | 7 % | 3,808,144 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $236.33 M | 7 % | 4,300,000 | ||
AKRO AKERO THERAPEUTICS INC | COM | 00973Y108 | $189.97 M | 5 % | 4,000,978 | ||
APLS APELLIS PHARMACEUTICALS INC | COM | 03753U106 | $181.05 M | 5 % | 8,000,382 | ||
TARS TARSUS PHARMACEUTICALS INC | COM | 87650L103 | $178.29 M | 5 % | 3,000,000 | ||
IMVT IMMUNOVANT INC | COM | 45258J102 | $156.83 M | 4 % | 9,728,845 | ||
DVAX DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | $156.16 M | 4 % | 15,726,349 | ||
OCUL OCULAR THERAPEUTIX INC | COM | 67576A100 | $139.49 M | 4 % | 11,932,137 | ||
ETNB 89BIO INC | COM | 282559103 | $137.54 M | 4 % | 9,356,171 |
Rows Per Page
10
- 10
- 50
- 100